Related references
Note: Only part of the references are listed.Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
Joseph S. Solomkin et al.
CLINICAL INFECTIOUS DISEASES (2010)
Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections
Joseph Solomkin et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Moxifloxacin for the Treatment of Patients with Complicated Intra-abdominal Infections (the AIDA Study)
G. Weiss et al.
JOURNAL OF CHEMOTHERAPY (2009)
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections:: Emerging resistance to carbapenems
Chia-Ying Liu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in Greece
Joseph Papaparaskevas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
National survey on the susceptibility of Bacteroides fragilis group:: Report and analysis of trends in the united states from 1997 to 2004
D. R. Snydman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria
Ingrid Wybo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections
Mark A. Malangoni et al.
ANNALS OF SURGERY (2006)
Changing patterns of fluoroquinolone resistance among Bacteroides fragilis group organisms over a 6-year period (1997-2002)
C Betriu et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2005)
Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe
M Hedberg et al.
CLINICAL MICROBIOLOGY AND INFECTION (2003)
Increase in resistance to new fluoroquinolones from 1998 to 2001 in the Bacteroides fragilis group
J Oteo-Iglesias et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Antimicrobial resistance and clinical outcome of bacteroides bacteremia: Findings of a multicenter prospective observational trial
MH Nguyen et al.
CLINICAL INFECTIOUS DISEASES (2000)
Share Paper
